AzTrials
AzTrials

Sleep Apnea, ObstructiveSLP-PAPNCT06786117

Swallowing in OSA & CPAP Intolerance

A study testing SLP swallowing exercises and myofunctional exercises in people with Sleep Apnea, Obstructive and Healthy, run by Denise Dewald at 1 site in United States.

Enrolling by invitation

Enrolling by invitation. The study team selects and invites participants, usually from an existing group of patients.

Sites and contacts
Official record
Search all trials

Trial summary

This study has two parts: an observational part and an interventional part. The goal of the observational part of the study is to look for variations in swallowing in adults with obstructive sleep apnea (OSA) and in adults who don't snore. Read more about this study

Who is it for?
Ages 40 to 70 yearsHealthy volunteers can take part
Conditions the study is for
Sleep Apnea, Obstructive, Healthy
What is being tested?
SLP swallowing exercises and myofunctional exercises
Type of treatment
Pill or oral medicine
Could I receive a placebo?
No, everyone receives an active treatment
How many people
50 participants
Where
1 siteUnited States
Study dates
5 Mar 2025to 30 Jan 2028
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 40 to 70 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Naturally ideal dental occlusion without orthodontic intervention, including successful eruption of wisdom teeth (without significant dental crowding, though minor rotation of less than 4 teeth will be acceptable)
  • No sleep-related complaints
  • No snoring.
  • They should be missing no more than 4 of their natural teeth, and these should have been lost to decay or accident rather than due to crowding. A person whose wisdom teeth came in successfully but were extracted "preventatively" will be eligible for the study.
  • Should be getting at least 6 hours of sleep nightly.
  • BMI between 18.5 and 35
Show all 22Show fewer
  • Inclusion Criteria for participants with OSA who are successful CPAP users:
  • Participant will have experienced significant benefits from therapy and have had such benefit since the first night of use. Participant should have no significant sleep complaints when using CPAP.
  • Uses CPAP > 6 hours of nightly use on > 90% of nights using a nasal mask.
  • Residual device AHI < 5 events/hour.
  • Has used CPAP for at least 12 months.
  • Symptomatic at diagnosis, with polysomnography (PSG) showing AASM AHI 5-60 and symptoms attributable to OSA, with greater than 75% of the apneas and hypopneas being obstructive in nature. Home sleep apnea testing (HSAT) will also be accepted, with RDI 5-60, with greater than 75% of the apneas and hypopneas being obstructive in nature.
  • Should be getting at least 6 hours of sleep nightly.
  • BMI between 18.5 and 35
  • Inclusion Criteria for participants with OSA who have CPAP intolerance:
  • Symptomatic, with polysomnography (PSG) showing AASM AHI 5-60 and symptoms attributable to OSA, with greater than 75% of the apneas and hypopneas being obstructive in nature. Home sleep apnea testing (HSAT) will also be accepted, with RDI 5-60, with greater than 75% of the apneas and hypopneas being obstructive in nature.
  • Attempted nightly use for at least 2 weeks (at least 12/14 nights), with average use < 4 hours, and difficulty tolerating PAP during a titration study, with complaints of difficulty breathing with CPAP or other difficulties that are not clearly related to identifiable causes (claustrophobia, mask discomfort, untreated RLS, untreated mouth leak, poor sleep hygiene, drug use, etc.).
  • Must be able to breathe through their noses comfortably while awake.
  • Able and willing to do daily swallowing exercises (15-30 minutes per day) for a total of 14 weeks.
  • Able and willing to use a positional therapy device to avoid supine sleep and to adjust their CPAP device settings (instructions will be provided).
  • BMI between 18.5 and 35
  • Not actively undergoing bariatric treatment or planning to start bariatric treatment within the next 6 months.

Who cannot join

  • Presence of symptomatic swallowing disorders, neuromuscular disorders affecting the upper airway, or neurodegenerative disorders.
  • Co-existing sleep disorders such as narcolepsy, untreated restless legs syndrome, circadian rhythm disorders, or behavioral insomnia/poor sleep hygiene.
  • Clinically significant congenital or acquired anomalies or history of surgery on the head and neck, excluding adenotonsillectomy, turbinate reduction, and septoplasty. Participants who had a tongue tie release outside of the newborn period will be excluded, but those who had tongue tie release in the newborn period will be eligible.
  • Known complex sleep apnea or a history of conditions that are associated with the development of complex sleep apnea, such as heart failure, atrial fibrillation, a history of stroke, or opioid use.
  • Prescription or nonprescription stimulant use (excluding caffeine).
  • Substance use disorder or nightly alcohol consumption, as these significantly interfere with normal sleep.
Show all 13Show fewer
  • Current unstable illness (such as asthma, hypertension, cancer, etc.), kidney failure with restrictions on fluid consumption, or unplanned hospitalization in the past year for an ongoing condition.
  • Risk factors for harm from expiratory strength testing and training: history of spontaneous pneumothorax, presence of CSF drain, recent trauma involving head, neck, or chest, history of recurrent epistaxis, history of esophageal surgery, active or recent hemoptysis, history of lung transplant or lung resection, eardrum rupture or any other condition of the ear, uncontrolled gastroesophageal reflux, abdominal hernia or recent hernia repair, urinary or fecal incontinence, presence of aneurysm (such as cerebral or aortic).
  • Participants with CPAP intolerance only: Latex allergy in themselves or household members (due to balloon use in exercises).
  • Allergy to Micropore paper tape (used in home sleep testing and for participants with CPAP intolerance during 2-week CPAP trial and exercise intervention).
  • Pregnancy, actively trying to get pregnant, or sexually active and not using birth control (for people of child-bearing potential).
  • Has a condition that increases the risk of developing cancer, such as BRCA1/2.
  • Does not speak English fluently.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

United States1 site
  • MetroHealth Medical Center

    Cleveland, Ohio, 44109

Other trials in United States

About this study

Official title: Swallowing in Obstructive Sleep Apnea (OSA) & Continuous Positive Airway Pressure (CPAP) Intolerance

This study has two parts: an observational part and an interventional part.

The goal of the observational part of the study is to look for variations in swallowing in adults with obstructive sleep apnea (OSA) and in adults who don't snore. The main questions it aims to answer are:

Read more
  • Are there differences in swallowing between people with OSA and people who don't snore?
  • Are there differences in swallowing between people with OSA who do well with continuous positive airway pressure (CPAP) therapy and those who struggle with CPAP?

This may help us better understand what causes OSA, which may help us develop alternate ways to treat or even prevent OSA. It may also help us improve care for people with OSA who struggle with CPAP. Participants will be aged 40-60 years, except women up to the age of 70 will be included in the healthy control (non-snorer) group.

Participants will:

  • Undergo a type of x-ray study called a modified barium swallow study (MBS)
  • Come to MetroHealth Medical Center for a measurement visit to:
  • assess the strength of their tongue, lips, and cheeks
  • assess the strength of their breathing muscles
  • assess for restrictions in tongue mobility (tongue ties)
  • observe their resting breathing
  • take photos of their mouth and posture
  • take videos of them drinking and eating
  • Complete some questionnaires
  • For successful CPAP users: we will download data from the chip in their CPAP device
  • Do a home sleep test (except for successful CPAP users who have had a recent in-lab sleep test)

The goal of the interventional part of the study is to test swallowing exercises in people ages 40-60 years with OSA who struggle with CPAP. The main question it aims to answer is:

  • Can swallowing exercises help people who struggle with CPAP sleep better with CPAP?

Participants will:

  • Try to use CPAP for 2 weeks with individualized support
  • Do all the investigations listed in the observational part of the study
  • Do one or two courses of swallowing exercises, each of which would last 7 weeks. Participants will be asked to do daily exercises; exercises will take 20-30 minutes to perform.
  • Try to use CPAP for 2 weeks after the course of exercises
  • Repeat the investigations listed in the observational part of the study to see if changes occurred with the swallowing exercise intervention.
Read the detailed description

Obstructive sleep apnea (OSA) is a common disorder in which the throat narrows abnormally or even collapses fully during sleep. The narrowing leads to sleep disruption and increases the risk of many chronic health conditions. We do not understand why the throat narrows in some people during sleep but not in others. While being overweight or obese increases a person's risk of OSA, it is only one part of the problem. Some thin adults and children have OSA, and many overweight or obese people do not have OSA. In addition, many people with OSA struggle to benefit from current OSA treatments like continuous positive airway pressure (CPAP), which uses air pressure to hold the airway open during sleep. We need improved understanding of OSA in order to improve treatment of it.

The throat is used for swallowing as well as for breathing. Hence it should not be surprising if a throat that has trouble staying open during sleep might also have some abnormalities during swallowing. Indeed, some research has shown subtle abnormalities in swallowing in people who have snoring or OSA compared to people who don't snore at all. We would like to further develop this line of research.

This study has two arms: an observational arm to look for differences in swallowing, and an interventional arm to see if swallowing exercises can improve people's ability to use CPAP.

The purpose of the observational arm is to look for differences in swallowing between healthy people and people who have obstructive sleep apnea (OSA) using a variety of measurement techniques, some of which have not been done in the past. Understanding the differences in swallowing may help us to develop new treatments for OSA. It may also help us to figure out how to prevent OSA from developing in the first place. We are also looking to see if there are swallowing differences between people with OSA who don't tolerate CPAP compared to people who do well with CPAP. If there are differences, these differences may help us better understand why some people do not tolerate CPAP, and may lead to the development of novel treatments such as exercise therapies to help them do better with CPAP.

The interventional arm will test exercise therapies to see if they will help people who struggle with CPAP. The goal is not to cure OSA, but to help people be able to use CPAP better so that they can sleep better. Participants who have abnormalities in their swallowing study will get exercises from speech language pathologists (SLP, also known as speech therapists) aimed at trying to correct those abnormalities. Participants will then try to use CPAP again. Participants who still can't sleep well with CPAP after those exercises, or who don't have abnormalities on the swallowing study, will get another type of exercise therapy based on an exercise technique called orofacial myofunctional therapy (OMT). This therapy aims to train exclusive nasal breathing and correct variations in the swallow. This sort of exercise technique has had some success in improving CPAP use as well as in reducing the severity of OSA. We have created a streamlined exercise protocol based on these techniques that we hope will provide better results in a shorter period of time. At the end of the exercise interventions, the participants will repeat the investigations that were done at the beginning of the study.

Investigations will include home sleep testing, CPAP trials (only for participants with OSA and CPAP intolerance), a modified barium swallow study (MBS), a measurement visit, and questionnaires. During the measurement visit, there will be assessments of the strength of the tongue, lips, and cheeks, assessment of nasal airflow, respiratory muscle strength, restrictions in tongue mobility (tongue tie), posture, dental and facial form, and eating and drinking. The modified barium swallow study uses x-rays; the amount of radiation from the procedure is about what a person would receive from about 4.5 months of background radiation. It is a little bit more radiation than what a person would receive from a mammogram, but much less than what a person would receive from a CT scan.

Being tested
SLP swallowing exercises, myofunctional exercises
Keywords
OSA, obstructive sleep apnea, sleep apnea, myofunctional therapy, swallowing exercises, speech language pathology, modified barium swallow, CPAP, CPAP intolerance, CPAP adherence, continuous positive airway pressure, EMST-150, expiratory muscle strength training, respiratory muscle strength, respiratory muscle strength training, non-snorers
Medical subject headings
Sleep Apnea, Obstructive, Sleep Apnea Syndromes

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • SLP swallowing exercisesOther

    Also called speech language pathology exercises, SLP exercises

    Clinical speech language pathologists will provide standard exercises based on the abnormalities seen on the modified barium swallow. Exercises are expected to include the effortful swallow, the Mendelsohn maneuver, expiratory muscle strength training with the EMST-150, supraglottic swallow, super supraglottic swallow, chin tuck against resistance isokinetic exercise, chin tuck against resistance isometric exercise, Masako maneuver, Shaker isometric head lift exercise, Shaker isokinetic head lift exercise, Falsetto high pitch glide exercise, tongue press exercise

  • myofunctional exercisesOther

    Also called orofacial myofunctional therapy (OMT), OMT exercises

    Participants will get a variety of exercises aimed at improving bolus formation, strengthening the seal of the soft palate with the tongue, and habituating nasal breathing. There will also be exercises aimed at stabilizing the epiglottis and strengthening the muscles supporting the lateral pharyngeal walls. Expiratory muscle strength training with the EMST-150 will also be done.

Study groups in NCT06786117
Study groupRoleWhat they receive
Healthy airways groupNo interventionParticipants will get a home sleep test to verify that sleep disordered breathing is not present. They will do a modified barium study (MBS) and a measurement visit to assess oral and respiratory muscle strength, nasal airflow, tongue mobility, eating and drinking, dental and facial form, and posture. They will also fill out some questionnaires.
Successful CPAP userNo interventionParticipants who do well will CPAP will do a modified barium study (MBS) and a measurement visit to assess oral and respiratory muscle strength, tongue mobility, nasal airflow, eating and drinking, dental and facial form, and posture. They will also fill out some questionnaires. Participants will also provide their CPAP data on an SD card. Participants will also do a home sleep test if there is no recent sleep study available.
CPAP intolerant - SLP exercises onlyExperimentalCPAP intolerant participants will try to use CPAP for two weeks with individualized coaching. If they still have problems with CPAP, they will do a modified barium study (MBS), a baseline home sleep test, and a measurement visit. During the measurement visit their oral and respiratory strength, nasal airflow, tongue mobility, eating and drinking, dental and facial form, and posture will be assessed. They will also fill out questionnaires. Participants with abnormalities on their MBS will get a 7-week course of standard swallowing exercises, with weekly in-person visits with a speech pathologist. They will be expected to do daily exercises (which will take 20-30 minutes). They will then try to use CPAP for two weeks to see if they are able to use CPAP better. If they do well with CPAP or are still struggling with CPAP but do not want to continue onto the myofunctional therapy arm, they will do an MBS, home sleep test, questionnaires, and the measurement visit again.
Receives: Other: SLP swallowing exercises
CPAP intolerant - OMT exercises onlyExperimentalCPAP intolerant participants will try to use CPAP for two weeks with individualized coaching. If they still have problems with CPAP, they will do a modified barium study (MBS), a baseline home sleep test, and also a measurement visit. During the measurement visit their oral and respiratory strength, tongue mobility, nasal airflow, eating and drinking, dental and facial form, and posture will be assessed. They will also fill out some questionnaires. CPAP intolerant participants without abnormalities on their MBS will get oral myofunctional therapy (OMT) exercises. The course of exercises will take 7 weeks to complete, with weekly video follow up visits. The exercises will take 20-30 minutes to do over the course of the day. After completing the 7-week course, participants will repeat the home sleep test, modified barium study, questionnaires, and measurement visit, and will once more try using CPAP for two weeks to see if they are able to use CPAP better.
Receives: Other: myofunctional exercises
CPAP intolerant - SLP and OMTExperimentalCPAP intolerant participants will try to use CPAP for two weeks with individualized coaching. If they still have problems with CPAP, they will do a modified barium study (MBS), a baseline home sleep test, and also a measurement visit. During the measurement visit their oral and respiratory strength, nasal airflow, tongue mobility, eating and drinking, dental and facial form, and posture will be assessed. They will also fill out questionnaires. Participants with abnormalities on their MBS will get standard swallowing exercises based on the abnormalities. They will then try using CPAP for two weeks. If they do not improve their CPAP tolerance with standard swallowing exercises, they will do a course of myofunctional therapy exercises. Both courses will be 7 weeks long, with daily exercises to do at home lasting 20-30 min. They will then repeat the home sleep test, MBS, questionnaires, and measurement visit, and will try using CPAP for two weeks to see if they can use CPAP better.
Receives: Other: SLP swallowing exercises; Other: myofunctional exercises

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Prevalence of premature spillage in participants with OSA who are CPAP intolerant vs participants who are successful nasal CPAP users or who have healthy airways

    MBS images will be evaluated for premature spillage during oral bolus formation. Comparison of prevalence of premature spillage will be made between study groups.

    Measured: at the time of MBS (within 2-4 weeks of study enrollment)

  2. Effect of swallowing exercise intervention for CPAP intolerance

    The effect of a swallowing exercise intervention on CPAP intolerance will be assessed, as reflected by change in usage from the participants' own pre-treatment CPAP data.

    The results of the two exercise interventions will be pooled, as the goal is to see if swallowing exercises can improve CPAP tolerance rather than to compare therapies.

    Measured: 3-7 months after enrollment

Secondary outcomes (69)
  1. Baseline length of the oropharyngeal seal during bolus formation in the modified barium swallow study (MBS)

    The length of the oropharyngeal seal during bolus formation will be measured to assess for differences between participants with healthy airways and those with OSA.

    Measured: at the time of MBS (within 2-4 weeks of study enrollment)

  2. Baseline breathing route during wakefulness as assessed by MBS

    Breathing route (oral, oronasal, or nasal) will be determined by soft palate position during resting breathing under fluoroscopy in the modified barium swallow study. Comparison will be made between healthy airways, CPAP intolerant, and successful CPAP user groups.

    Measured: at the time of MBS (within 2-4 weeks of study enrollment)

  3. Baseline tongue position as observed during nasal breathing during MBS

    A high or low tongue resting position during nasal breathing will be noted upon review of the MBS images. Tongue position will be compared between study groups.

    Measured: at the time of MBS (within 2-4 weeks of study enrollment)

  4. Baseline soft palate shape as observed during nasal breathing during MBS

    Assessment of the angulation of the soft palate during nasal breathing will be performed. Results will be compared between healthy airways, CPAP intolerant, and successful CPAP user groups.

    Measured: at the time of MBS (within 2-4 weeks of study enrollment)

  5. Baseline assessment of Tipper- vs Dipper-type oral swallowing

    The presence of Tipper-type vs Dipper-type oral swallowing will be assessed by MBS. The prevalence of the oral swallowing types in the study groups will be compared.

    Measured: at the time of MBS (within 2-4 weeks of study enrollment)

  6. Baseline assessment of anterior tongue strength

    Assessment of anterior tongue strength will be made using an IOPI (Iowa Oral Performance Index) system. Strength will be compared between groups.

    Measured: at the time of the measurement visit (within 2-4 weeks of study enrollment); participants with CPAP intolerance will have a second measurement visit at the end of the study

  7. Baseline assessment of posterior tongue strength

    Assessment of posterior tongue strength will be made using an IOPI (Iowa Oral Performance Index) system. Strength will be compared between groups.

    Measured: at the time of the measurement visit (within 2-4 weeks of study enrollment)

  8. Baseline assessment of combined lip/cheek strength

    Assessment of combined lip/cheek strength will be made using an IOPI (Iowa Oral Performance Index) system. Strength will be compared between groups.

    Measured: at the time of the measurement visit (within 2-4 weeks of study enrollment)

  9. Baseline assessment of combined lip/cheek activation during swallowing

    Assessment of combined lip/cheek activation during swallowing will be made using an IOPI (Iowa Oral Performance Index) system. Extent of combined lip/cheek activation during swallowing will be compared between groups.

    Measured: at the time of the measurement visit (within 2-4 weeks of study enrollment)

  10. Baseline maximum expiratory pressure

    Maximum expiratory pressure (MEP) will be assessed and compared between study groups.

    Measured: at the time of the measurement visit (within 2-4 weeks of study enrollment)

  11. Baseline maximum inspiratory pressure via oral route

    Maximum inspiratory pressure by the oral route will be assessed and compared between study groups.

    Measured: at the time of the measurement visit (within 2-4 weeks of study enrollment)

  12. Baseline sniff inspiratory pressure (SNIP) via nasal route

    Baseline maximum sniff inspiratory pressure (SNIP) by the nasal route will be assessed and compared between study groups.

    Measured: at the time of the measurement visit (within 2-4 weeks of study enrollment)

  13. Baseline awake resting breathing route assessment by nasal pressure signal

    Awake breathing route (oral, oronasal, or nasal) will be inferred by nasal pressure signal during resting breathing. Comparison will be made between healthy airways, CPAP intolerant, and successful CPAP user groups.

    Measured: at the time of the measurement visit (within 2-4 weeks of study enrollment)

  14. Baseline assessment of Mallampati score

    Mallampati score will be assessed by physical examination. Comparisons will be made between study groups.

    Measured: at the time of the measurement visit (within 2-4 weeks of study enrollment)

  15. Baseline assessment of Friedman tongue position score

    Friedman tongue position score will be assessed by physical examination. Comparisons will be made between study groups.

    Measured: at the time of the measurement visit (within 2-4 weeks of study enrollment)

  16. Baseline anterior tongue tie evaluation

    Anterior tongue tie evaluation will be made using the tongue tie assessment tool. Comparisons between groups will be made.

    Measured: at the time of the measurement visit (within 2-4 weeks of study enrollment)

  17. Baseline posterior tongue tie evaluation

    Posterior tongue tie evaluation will be made using the tongue tie assessment tool. Comparisons between groups will be made.

    Measured: at the time of the measurement visit (within 2-4 weeks of study enrollment)

  18. Baseline visual differences in swallowing

    Utilization of lip and cheek muscles during swallowing will be assessed visually (with videorecording). Comparisons will be made between the study groups.

    Measured: at the time of the measurement visit (within 2-4 weeks of study enrollment)

  19. Baseline head tilt angle differences

    Head tilt angle will be measured by glasses with an attached digital level. Comparisons will be made between study groups.

    Measured: at the time of the measurement visit (within 2-4 weeks of study enrollment)

  20. Baseline postural assessment

    Photographs will be taken with the participant standing next to a plumb line for postural assessment. Comparisons will be made between study groups.

    Measured: at the time of the measurement visit (within 2-4 weeks of study enrollment)

  21. Baseline CPAP waveform differences between participants with CPAP intolerance and participants who are successful CPAP users (participants with OSA only)

    CPAP waveforms will be assessed for the presence of negative effort dependence or other differences in the airflow waveform shapes in participants with CPAP intolerance compared to participants who are successful nasal CPAP users.

    Measured: At study enrollment (successful CPAP users) or after baseline 2-week CPAP trial (participants with CPAP intolerance), within 1 months of enrollment

  22. Baseline differences in nasal pressure signal during sleep between participants with CPAP intolerance and participants who are successful CPAP users (participants with OSA only)

    Nasal pressure waveforms during sleep will be assessed for the presence of negative effort dependence or other features that may be different between participants with CPAP intolerance compared to participants who are successful nasal CPAP users, as seen in polysomnography or home sleep testing.

    Measured: At enrollment (if recent PSG is already available) or after completion of home sleep testing, within one month of enrollment

  23. Baseline Swallowing Disturbance Questionnaire

    Participants will complete the Swallowing Disturbance Questionnaire. Responses will be compared between study groups.

    Measured: When baseline questionnaires are returned, within one month of enrollment.

  24. Baseline Epworth Sleepiness Scale (ESS)

    Participants will complete the Epworth Sleepiness Scale (ESS) questionnaire. Comparisons will be made between study groups.

    Measured: When baseline questionnaires are returned, within one month of enrollment.

  25. Baseline Pittsburgh Sleep Quality Index (PSQI) questionnaire

    Participants will complete the Pittsburgh Sleep Quality Index (PSQI) questionnaire. Comparisons will be made between study groups.

    Measured: When baseline questionnaires are returned, within one month of enrollment.

  26. Baseline Insomnia Severity Index (ISI) questionnaire

    Participants will complete the Insomnia Severity Index (ISI) questionnaire. Comparisons will be made between study groups.

    Measured: When baseline questionnaires are returned, within one month of enrollment.

  27. Baseline Short Calgary Sleep Apnea Quality Of Life Index questionnaire

    Participants will complete the Short Calgary Sleep Apnea Quality Of Life Index questionnaire. Comparisons will be made between study groups.

    Measured: When baseline questionnaires are returned, within one month of enrollment.

  28. Baseline Short Form Health Survey-36 questionnaire

    Participants will complete the Short Form Health Survey-36 questionnaire. Comparisons will be made between study groups.

    Measured: When baseline questionnaires are returned, within one month of enrollment.

  29. Baseline PROMIS Sleep Disturbance short form 8b questionnaire

    Participants will complete the PROMIS Sleep Disturbance short form 8b questionnaire. Comparisons will be made between study groups.

    Measured: When baseline questionnaires are returned, within one month of enrollment.

  30. Baseline PROMIS Sleep-related impairment short form 8a questionnaire

    Participants will complete the PROMIS Sleep-related impairment short form 8a questionnaire. Comparisons will be made between study groups.

    Measured: When baseline questionnaires are returned, within one month of enrollment.

  31. Baseline sleep habits and swallowing and CPAP observations questionnaire

    Participants will complete questionnaires on sleep habits and swallowing and CPAP observations. Responses will be compared between study groups.

    Measured: When baseline questionnaires are returned, within one month of enrollment.

  32. Post-intervention assessment of AHI by home sleep testing (participants with CPAP intolerance only)

    Repeat home sleep testing will be performed after the final swallowing exercise intervention has been completed (before the CPAP trial or two weeks after the CPAP trial). Results will be compared with the participant's baseline home sleep test.

    Measured: Before the post-intervention CPAP trial or two weeks after the CPAP trial, which will be approximately 3-7 months after enrollment, depending on whether one or two courses of exercises is done

  33. Post-intervention changes in nasal airflow during sleep (participants with CPAP intolerance only)

    Nasal pressure signal on home sleep testing will be assessed for changes in flow limitation and negative effort dependence after the intervention, and compared to the participant's pre-intervention waveforms.

    Measured: Before the post-intervention CPAP trial or two weeks after the CPAP trial, which will be approximately 3-7 months after enrollment, depending on whether one or two courses of exercises is done

  34. Post-intervention assessment of pulse oxygen nadir by home sleep testing (participants with CPAP intolerance only)

    Repeat home sleep testing will be performed after the final swallowing exercise intervention has been completed (before the CPAP trial or two weeks after the CPAP trial). Pulse oxygen nadir will be determined and compared with the participant's baseline home sleep test.

    Measured: Before the post-intervention CPAP trial or two weeks after the CPAP trial, which will be approximately 3-7 months after enrollment, depending on whether one or two courses of exercises is done

  35. Post-intervention assessment of time with oxygen saturation less than 90% during home sleep testing (participants with CPAP intolerance only)

    Repeat home sleep testing will be performed after the final swallowing exercise intervention has been completed (before the CPAP trial or two weeks after the CPAP trial). The time spent with oxygen saturation less than 90% will be determined and compared with the participant's baseline home sleep study.

    Measured: Before the post-intervention CPAP trial or two weeks after the CPAP trial, which will be approximately 3-7 months after enrollment, depending on whether one or two courses of exercises is done

  36. Post-intervention differences in nasal pressure signal during home sleep testing (participants with CPAP intolerance only)

    Post-intervention nasal pressure waveforms during home sleep testing will be assessed for the presence of negative effort dependence or other changes. Results will be compared to participant's baseline results and to those of participants who are successful nasal CPAP users, as seen in polysomnography or home sleep testing.

    Measured: After the post-intervention 2-week CPAP trial, 3-7 months after study enrollment

  37. Post-intervention assessment of oral bolus formation during MBS (participants with CPAP intolerance only)

    Repeat MBS after the swallowing exercise intervention will be done to assess for any changes in oral bolus formation/premature spillage.

    Measured: Within 2-4 weeks of the completion of the final swallowing exercise intervention, which will be 3-7 months after enrollment

  38. Post-intervention length of oropharyngeal seal during bolus formation in modified barium swallow study (MBS) (participants with CPAP intolerance only)

    The length of the oropharyngeal seal during oral bolus formation will be measured on MBS. Results will be compared to the participant's baseline MBS.

    Measured: at the time of the post-intervention MBS, approximately 3-7 months after enrollment, depending on whether one or two courses of exercises is done

  39. Post-intervention breathing route during wakefulness by MBS (participants with CPAP intolerance only)

    Breathing route (oral, oronasal, or nasal) will be determined by soft palate position during resting breathing under fluoroscopy in the repeat modified barium swallow study, to be done after completion of the final exercise intervention. Comparison will be made to the participant's baseline results.

    Measured: at the time of the post-intervention MBS, approximately 3-7 months after enrollment, depending on whether one or two courses of exercises is done

  40. Post-intervention tongue position as observed during nasal breathing during MBS (participants with CPAP intolerance only)

    A high or low tongue resting position during nasal breathing will be noted upon review of the MBS images. Tongue position will be compared to participant's baseline results.

    Measured: at the time of the post-intervention MBS, approximately 3-7 months after enrollment, depending on whether one or two courses of exercises is done

  41. Post-intervention soft palate shape as observed during nasal breathing during MBS (participants with CPAP intolerance only)

    Assessment of the angulation of the soft palate during nasal breathing will be performed. Results will be compared to the participant's baseline.

    Measured: at time of the post-intervention MBS, approximately 3-7 months after enrollment, depending on whether one or two courses of exercises is done

  42. Post-intervention assessment of Tipper- vs Dipper-type swallowing (participants with CPAP intolerance only)

    The presence of Tipper-type vs Dipper-type oral swallowing will be assessed by repeat MBS. The results will be compared to the participant's baseline.

    Measured: at the time of the post-intervention MBS, approximately 3-7 months after enrollment, depending on whether one or two courses of exercises is done

  43. Post-intervention assessment of anterior tongue strength (participants with CPAP intolerance only)

    Assessment of anterior tongue strength will be made using an IOPI (Iowa Oral Performance Index) system during the post-intervention measurement visit. Strength will be compared to participant's baseline and to baseline results for the other study groups.

    Measured: at the time of the post-intervention measurement visit, approximately 3-7 months after enrollment, depending on whether one or two courses of exercises is done

  44. Post-intervention assessment of posterior tongue strength (participants with CPAP intolerance only)

    Assessment of posterior tongue strength will be made using an IOPI (Iowa Oral Performance Index) system during the post-intervention measurement visit. Strength will be compared to participant's baseline and to baseline results for the other study groups.

    Measured: at the time of the post-intervention measurement visit, approximately 3-7 months after enrollment, depending on whether one or two courses of exercises is done

  45. Post-intervention assessment of combined lip/cheek strength (participants with CPAP intolerance only)

    Assessment of combined lip/cheek strength will be made using an IOPI (Iowa Oral Performance Index) system during the post-intervention measurement visit. Strength will be compared to participant's baseline and to baseline results for the other study groups.

    Measured: at the time of the post-intervention measurement visit, approximately 3-7 months after enrollment, depending on whether one or two courses of exercises is done

  46. Post-intervention assessment of combined lip/cheek activation during swallowing (participants with CPAP intolerance only)

    Repeat assessment of combined lip/cheek activation during swallowing will be made using an IOPI (Iowa Oral Performance Index) system. Extent of lip/cheek activation during swallowing will be compared to participant's baseline results and also to the baseline results of the other study groups.

    Measured: at the time of the post-intervention measurement visit, approximately 3-7 months after enrollment, depending on whether one or two courses of exercises is done

  47. Post-intervention maximum expiratory pressure (participants with CPAP intolerance only)

    Maximum expiratory pressure (MEP) will be assessed post-intervention and compared to participant's baseline and the baseline results of the other study groups.

    Measured: at the time of the post-intervention measurement visit, approximately 3-7 months after enrollment, depending on whether one or two courses of exercises is done

  48. Post-intervention maximum inspiratory pressure via oral route (participants with CPAP intolerance only)

    Maximum inspiratory pressure by the oral route will be assessed post-intervention. Results will be compared to participant's baseline results and to baseline results of other study groups.

    Measured: at the time of the post-intervention measurement visit, approximately 3-7 months after enrollment, depending on whether one or two courses of exercises is done

  49. Post-intervention sniff inspiratory pressure (SNIP) via nasal route (participants with CPAP intolerance only)

    Post-intervention maximum sniff inspiratory pressure (SNIP) by the nasal route will be assessed. Results will be compared to participant's baseline values and between those of the other study groups.

    Measured: at the time of the post-intervention measurement visit, approximately 3-7 months after enrollment, depending on whether one or two courses of exercises is done

  50. Post-intervention awake resting breathing route assessment by nasal pressure signal (participants with CPAP intolerance only)

    Post-intervention awake breathing route (oral, oronasal, or nasal) will be determined by nasal pressure signal during resting breathing. Comparison will be made to participant's baseline results and to those of the other study groups.

    Measured: at the time of the post-intervention measurement visit, approximately 3-7 months after enrollment, depending on whether one or two courses of exercises is done

  51. Post-intervention assessment of Mallampati score (participants with CPAP intolerance only)

    Post-intervention Mallampati score will be assessed by physical examination. Comparisons will be made to participant's baseline value and to the Mallampati scores of the other study groups.

    Measured: at the time of the post-intervention measurement visit, approximately 3-7 months after enrollment, depending on whether one or two courses of exercises is done

  52. Post-intervention assessment of Friedman tongue position score (participants with CPAP intolerance only)

    Post-intervention Friedman tongue position score will be assessed by physical examination. Comparisons will be made to participant's baseline score and also to scores of the other study groups.

    Measured: at the time of the post-intervention measurement visit, approximately 3-7 months after enrollment, depending on whether one or two courses of exercises is done

  53. Post-intervention anterior tongue tie evaluation (participants with CPAP intolerance only)

    Repeat anterior tongue tie evaluation will be made using the tongue tie assessment tool. Comparisons to participant's baseline results and the results of other study groups will be made.

    Measured: at the time of the post-intervention measurement visit, approximately 3-7 months after enrollment, depending on whether one or two courses of exercises is done

  54. Post-intervention posterior tongue tie evaluation (participants with CPAP intolerance only)

    Post-intervention posterior tongue tie evaluation will be made using the tongue tie assessment tool. Result will be compared to participant's baseline result and to the results of the other study groups.

    Measured: at the time of the post-intervention measurement visit, approximately 3-7 months after enrollment, depending on whether one or two courses of exercises is done

  55. Post-intervention visual differences in swallowing (participants with CPAP intolerance only)

    Post-intervention utilization of lip and cheek muscles during swallowing will be assessed visually (with videorecording). Comparisons will be made to the participant's baseline results and to the results of the other study groups.

    Measured: at the time of the post-intervention measurement visit, approximately 3-7 months after enrollment, depending on whether one or two courses of exercises is done

  56. Post-intervention head tilt angle differences (participants with CPAP intolerance only)

    Post-intervention head tilt angle will be measured by glasses with an attached digital level. Comparisons will be made to participant's baseline value and to those of the other study groups.

    Measured: at the time of the post-intervention measurement visit, approximately 3-7 months after enrollment, depending on whether one or two courses of exercises is done

  57. Post-intervention postural assessment (participants with CPAP intolerance only)

    Post-intervention photographs will be taken with the participant standing next to a plumb line for postural assessment. Comparisons will be made to participant's baseline results and to those of the other study groups.

    Measured: at the time of the post-intervention measurement visit, approximately 3-7 months after enrollment, depending on whether one or two courses of exercises is done

  58. Post-intervention CPAP waveform differences (participants with CPAP intolerance only)

    After the final 2-week CPAP trial, CPAP waveforms will be obtained from the CPAP data chip and assessed for the presence of negative effort dependence or other differences in the airflow waveform shapes. Results will be compared to participant's pre-intervention results and those of participants who are successful nasal CPAP users.

    Measured: After the post-intervention 2-week CPAP trial, 3-7 months after study enrollment.

  59. Post-intervention CPAP residual AHI (participants with CPAP intolerance only)

    Residual AHI will be collected from the CPAP data chip after 2-week CPAP trial at the end of the swallowing exercise intervention. Results will be compared to participant's pre-intervention results and those of participants who are successful nasal CPAP users.

    Measured: After the post-intervention 2-week CPAP trial, 3-7 months after study enrollment.

  60. Post-intervention number of nightly CPAP mask removals (participants with CPAP intolerance only)

    The number of nightly CPAP mask removals will be collected from the CPAP data chip after 2-week CPAP trial at the end of the swallowing exercise intervention. Results will be compared to participant's pre-intervention results and those of participants who are successful nasal CPAP users.

    Measured: After the post-intervention 2-week CPAP trial, 3-7 months after study enrollment.

  61. Post-intervention Swallowing Disturbance Questionnaire (participants with CPAP intolerance only)

    Participants will complete a second Swallowing Disturbance Questionnaire after completing the final exercise intervention. Responses will be compared to their baseline questionnaire.

    Measured: When the post-intervention questionnaires are returned, which will be approximately 3-7 months after enrollment, depending on whether one or two courses of exercises is done

  62. Post-intervention Epworth Sleepiness Scale (ESS) (participants with CPAP intolerance only)

    Participants will complete a second Epworth Sleepiness Scale (ESS) questionnaire after completing the final exercise intervention. Comparison will be made to the participant's baseline results.

    Measured: When the post-intervention questionnaires are returned, which will be approximately 3-7 months after enrollment, depending on whether one or two courses of exercises is done

  63. Post-intervention Pittsburgh Sleep Quality Index (PSQI) questionnaire (participants with CPAP intolerance only)

    Participants will complete a second Pittsburgh Sleep Quality Index (PSQI) questionnaire after completing the final exercise intervention. Comparison will be made to participant's baseline results.

    Measured: When the post-intervention questionnaires are returned, which will be approximately 3-7 months after enrollment, depending on whether one or two courses of exercises is done

  64. Post-intervention Insomnia Severity Index (ISI) questionnaire (participants with CPAP intolerance only)

    Participants will complete a second Insomnia Severity Index (ISI) questionnaire after completing the final exercise intervention. Comparison will be made to participant's baseline results.

    Measured: When the post-intervention questionnaires are returned, which will be approximately 3-7 months after enrollment, depending on whether one or two courses of exercises is done

  65. Post-intervention Short Calgary Sleep Apnea Quality Of Life Index questionnaire (participants with CPAP intolerance only)

    Participants will complete a second Short Calgary Sleep Apnea Quality Of Life Index questionnaire after completing the final exercise intervention. Comparison will be made to participant's baseline results.

    Measured: When the post-intervention questionnaires are returned, which will be approximately 3-7 months after enrollment, depending on whether one or two courses of exercises is done

  66. Post-intervention Short Form Health Survey-36 questionnaire (participants with CPAP intolerance only)

    Participants with CPAP intolerance will complete a second Short Form Health Survey-36 questionnaire after completion of the exercise intervention(s). Comparisons will be made to their responses on the baseline questionnaire.

    Measured: When the post-intervention questionnaires are returned, which will be approximately 3-7 months after enrollment, depending on whether one or two courses of exercises is done

  67. Post-intervention PROMIS Sleep Disturbance short form 8b questionnaire (participants with CPAP intolerance only)

    Participants will complete a second PROMIS Sleep Disturbance short form 8b questionnaire after completing the final exercise intervention. Comparison will be made to participant's baseline results.

    Measured: When the post-intervention questionnaires are returned, which will be approximately 3-7 months after enrollment, depending on whether one or two courses of exercises is done

  68. Post-intervention PROMIS Sleep-related impairment short form 8a questionnaire (participants with CPAP intolerance only)

    Participants will complete a second PROMIS Sleep-related impairment short form 8a after completing the final exercise intervention. Comparison will be made to participant's baseline results.

    Measured: When the post-intervention questionnaires are returned, which will be approximately 3-7 months after enrollment, depending on whether one or two courses of exercises is done

  69. Post-intervention sleep habits and swallowing and CPAP observations questionnaire (participants with CPAP intolerance only)

    Participants will complete repeat questionnaires on sleep habits and swallowing and CPAP observations after completing the final exercise intervention. Comparison will be made to participant's baseline results.

    Measured: When the post-intervention questionnaires are returned, which will be approximately 3-7 months after enrollment, depending on whether one or two courses of exercises is done

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted22 Jan 2025
  2. Study start5 Mar 2025
  3. Primary completion30 Dec 2026 (estimated)
  4. Study completion30 Jan 2028 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Non-randomised
Intervention model
Sequential
Masking
None (open label)
Enrolment
50 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06786117
Sponsor's protocol ID
STUDY0000450
Other IDs
299-JF-23
Acronym
SLP-PAP
Status last verified
Jan 2025
First submitted
6 Jan 2025
Last updated
11 Mar 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: All IDP collected throughout the trial.

Questions about this trial

What is this clinical trial studying?

A study testing SLP swallowing exercises and myofunctional exercises in people with Sleep Apnea, Obstructive and Healthy, run by Denise Dewald at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 22 inclusion and 13 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: enrolling by invitation, as of the sponsor's last update on 11 Mar 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Prevalence of premature spillage in participants with OSA who are CPAP intolerant vs participants who are successful nasal CPAP users or who have healthy airways (time frame: at the time of MBS (within 2-4 weeks of study enrollment)). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 11 Mar 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in